If your body develops anti-drug antibodies against tirzepatide, the medication may become less effective even when you switch to a fresh supply
This calculation does not include the potential costs of ineffective treatment, including delayed results, the psychological impact of slow progress, and the eventual cost of switching to injections after months of suboptimal response
Finally, avoid increasing tirzepatide doses during active antibiotic treatment unless explicitly instructed by your physician, as dose escalations compound nausea risk
[16] [21] The SURPASS-4 trial, which studied tirzepatide in patients with type 2 diabetes at high cardiovascular risk, included exploratory cardiovascular endpoints but was not designed as a definitive cardiovascular outcomes trial
Understanding Semaglutide Semaglutide is a prescription medication originally developed to treat type 2 diabetes it works by mimicking a hormone in the body called glucagon-like peptide-1 (GLP-1) that helps regulate blood sugar levels